These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 18068276
21. Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences? Ndiaye C, Alemany L, Ndiaye N, Kamaté B, Diop Y, Odida M, Banjo K, Tous S, Klaustermeier JE, Clavero O, Castellsagué X, Bosch FX, Trottier H, de Sanjosé S. Trop Med Int Health; 2012 Dec; 17(12):1432-40. PubMed ID: 23107344 [Abstract] [Full Text] [Related]
22. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries. Goldie SJ, O'Shea M, Campos NG, Diaz M, Sweet S, Kim SY. Vaccine; 2008 Jul 29; 26(32):4080-93. PubMed ID: 18550229 [Abstract] [Full Text] [Related]
23. HPV and cervical cancer in the 2007 report. WHO/ICO Information Centre on HPV and Cervical Cancer. Vaccine; 2007 Nov 01; 25 Suppl 3():C1-230. PubMed ID: 18068032 [No Abstract] [Full Text] [Related]
24. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination. Pitts M, Smith A, Croy S, Lyons A, Ryall R, Garland S, Wong ML, Hseon TE. Vaccine; 2009 May 14; 27(22):2989-93. PubMed ID: 19428910 [Abstract] [Full Text] [Related]
26. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal. Sankaranarayanan R, Bhatla N, Gravitt PE, Basu P, Esmy PO, Ashrafunnessa KS, Ariyaratne Y, Shah A, Nene BM. Vaccine; 2008 Aug 19; 26 Suppl 12():M43-52. PubMed ID: 18945413 [Abstract] [Full Text] [Related]
27. [Development of an HPV vaccine--remaining issues and perspective]. Kondo K. Nihon Rinsho; 2009 Jan 19; 67(1):62-8. PubMed ID: 19177753 [Abstract] [Full Text] [Related]
28. [Human papilloma virus and cervical cancer]. Berumen-Campos J. Gac Med Mex; 2006 Jan 19; 142 Suppl 2():51-9. PubMed ID: 19031679 [Abstract] [Full Text] [Related]
29. Human papillomavirus genotyping in histological sections of precursor lesions of cervical carcinoma: its role as a possible adjunct for the evaluation of the oncogenic potential of specific human papillomavirus genotypes - a study in a coastal region of southeastern Spain. Doménech-Peris A, Conesa-Zamora P, Sahuquillo-Frias L, Ortiz-Reina S, Moya-Biosca J, Acosta-Ortega J, Pérez-Guillermo M, Egea-Cortines M. Gynecol Obstet Invest; 2010 Jan 19; 70(2):113-9. PubMed ID: 20332645 [Abstract] [Full Text] [Related]
30. Prospects and prejudices of human papillomavirus vaccines in India. Das BC, Hussain S, Nasare V, Bharadwaj M. Vaccine; 2008 May 23; 26(22):2669-79. PubMed ID: 18455843 [Abstract] [Full Text] [Related]
31. Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for prevention. Castellsagué X, Klaustermeier J, Carrilho C, Albero G, Sacarlal J, Quint W, Kleter B, Lloveras B, Ismail MR, de Sanjosé S, Bosch FX, Alonso P, Menéndez C. Int J Cancer; 2008 Apr 15; 122(8):1901-4. PubMed ID: 18076064 [Abstract] [Full Text] [Related]
32. Human papillomavirus, cervical cancer, and the vaccines. Tovar JM, Bazaldua OV, Vargas L, Reile E. Postgrad Med; 2008 Jul 15; 120(2):79-84. PubMed ID: 18654072 [Abstract] [Full Text] [Related]
33. Human papillomavirus vaccines: an update for gynecologists. Ault KA. Clin Obstet Gynecol; 2008 Sep 15; 51(3):527-32. PubMed ID: 18677145 [Abstract] [Full Text] [Related]
34. Prevalence of human papillomavirus types in cervical and oral cancers in central India. Gheit T, Vaccarella S, Schmitt M, Pawlita M, Franceschi S, Sankaranarayanan R, Sylla BS, Tommasino M, Gangane N. Vaccine; 2009 Jan 29; 27(5):636-9. PubMed ID: 19056450 [Abstract] [Full Text] [Related]
35. [Implementation of HPV vaccination in Germany]. Schreckenberger C, Kaufmann AM, Schneider A. Dtsch Med Wochenschr; 2007 Oct 29; 132(42):2221-4. PubMed ID: 17926251 [No Abstract] [Full Text] [Related]
36. Prophylactic HPV vaccination for the prevention of cervical cancer. Hernandez BY. Hawaii Med J; 2007 Jul 29; 66(7):190-1. PubMed ID: 17879858 [No Abstract] [Full Text] [Related]
38. Integrating human papillomavirus vaccination in cervical cancer control programmes. Franco EL, Coutlée F, Ferenczy A. Public Health Genomics; 2009 Jul 29; 12(5-6):352-61. PubMed ID: 19684447 [Abstract] [Full Text] [Related]
39. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias. Paavonen J. Int J Infect Dis; 2007 Nov 29; 11 Suppl 2():S3-9. PubMed ID: 18162244 [Abstract] [Full Text] [Related]
40. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer. Wheeler CM. Obstet Gynecol Clin North Am; 2008 Dec 29; 35(4):519-36; vii. PubMed ID: 19061814 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]